Evommune, Inc. (NYSE: EVMN) — Healthcare · Share Price, Chart & Market Data
About: Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $25.38 (-1.78%)
EVMNEvommune, Inc.
Loading watchlist status…
Trade EVMN now
Evommune, Inc. share price
EVMN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:30 am GMT+0
EVMN price performance
-9.26%
5D
20.742%
1M
46.62%
YTD
25.457%
1Y
EVMN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:30 am GMT+0
EVMN details
EVMN Market Signals